NHS England Introduces Varenicline to Help Smokers Quit

NHS England is set to offer a once-a-day pill, varenicline, to help hundreds of thousands of smokers quit, aiming to save thousands of lives, The Guardian reported yesterday.

The initiative targets approximately 85,000 people annually, as NHS leaders believe the medication can significantly increase the chances of quitting smoking.

Varenicline, which reduces nicotine cravings and alleviates withdrawal symptoms, is considered as effective as vaping in aiding cessation efforts. Amanda Pritchard, CEO of NHS England, described the pill as a potential “gamechanger” in combating the health risks associated with smoking. The NHS hopes that this measure will lead to 9,500 fewer smoking-related deaths over the next five years.

Originally introduced in 2006 under the name Champix, varenicline was withdrawn in 2021 due to impurities but has since been reapproved. The generic version will be supplied by Teva UK, with research indicating it could save £1.65 in healthcare costs for every £1 spent on the drug. Smoking experts have welcomed its return, emphasizing the need for combined behavioral support for optimal results.